by John Hamlin Editorial note: This article was written prior to the new FDA Guidance for Aseptic Processing being published. The second part of this article to be published in the near future wi...
https://www.biorealty.com/blog/overview-of-aseptic-fillfinish-manufacturing/
By incorporating flexible design features in initial facility construction, biotechnology companies can move from pilot to production operations and market entry in a timely and cost-effective ma...
https://www.biorealty.com/blog/designing-a-flexible-facility-for-biopharmaceuticals/
Because government agencies, educational institutions, and pharmaceutical companies are becoming increasingly aware of the benefits that attracting biomedical companies to their area represents, ...
https://www.biorealty.com/blog/the-biomedical-industrys-emerging-clusters/